chevron_leftBack
E
As of 13 June 2026, Ernexa Therapeutics Inc. has a market cap of $7.17M USD, ranking #42917 globally and #5491 in the United States.
It ranks #3793 in the Healthcare sector, and #1226 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$7.17MUSD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -6.2% | -23% | -57% | -20% | -83% | -91% |
News
Loading...
ERNA Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ERNA
ISIN: US1140824079
Shares Out.:
Shares Outstanding:
1.166M1
Shares Float:
679.05K2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
6.15 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
11M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
8M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
5M%
|
97.4
|
|
NYSE: MRK
|
$274.03B
4M%
|
15.1
|
|
NYSE: PFE
|
$149.38B
2M%
|
19.5
|
|
NYSE: BMY
|
$117.58B
2M%
|
16.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SIX: RO
|
$321.52B
4M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
4M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
4M%
218.9B CHF
|
20.5
|
|
CPH: NOVO-B
|
$181.82B
3M%
1.18T DKK
|
11.5
|
|
EPA: SAN
|
$110.1B
2M%
95.26B EUR
|
19.9
|
|
LSE: GSK
|
$108.46B
2M%
80.96B GBP
|
14.6
|
chevron_leftBack